Fuller & Thaler Asset Management, Inc. Boston Scientific Corp Transaction History

Fuller & Thaler Asset Management, Inc.

$25 Billion
Q3 2024

A detailed history of Fuller & Thaler Asset Management, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Fuller & Thaler Asset Management, Inc. holds 7,575 shares of BSX stock, worth $743,637. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,575

Previous 7,575 -0.0%

Holding current value

$743,637

Previous $583,000 8.75%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$48.64 - $57.81 $75,392 - $89,605	1,550 Added 25.73%	7,575 $437,000
Q3 2023 Nov 13, 2023	BUY	$50.19 - $54.68 $15,057 - $16,404	300 Added 5.24%	6,025 $318,000
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $74,082 - $81,413	1,490 Added 35.18%	5,725 $309,000
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $98,900 - $118,050	-2,500 Reduced 37.12%	4,235 $196,000
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $85,350 - $254,959	-2,325 Reduced 25.66%	6,735 $261,000
Q2 2022 Aug 12, 2022	SELL	$35.24 - $47.1 $193,820 - $259,050	-5,500 Reduced 37.77%	9,060 $338,000
Q1 2022 May 13, 2022	SELL	$40.9 - $45.1 $196,320 - $216,480	-4,800 Reduced 24.79%	14,560 $645,000
Q4 2021 Feb 09, 2022	SELL	$38.07 - $44.87 $106,596 - $125,636	-2,800 Reduced 12.64%	19,360 $822,000
Q3 2021 Nov 10, 2021	SELL	$41.23 - $45.88 $61,844 - $68,820	-1,500 Reduced 6.34%	22,160 $962,000
Q2 2021 Aug 13, 2021	SELL	$38.58 - $44.24 $154,320 - $176,960	-4,000 Reduced 14.46%	23,660 $1.01 Million
Q1 2021 May 13, 2021	SELL	$35.27 - $39.67 $183,404 - $206,284	-5,200 Reduced 15.82%	27,660 $1.07 Million
Q4 2020 Feb 11, 2021	BUY	$33.15 - $41.97 $1,989 - $2,518	60 Added 0.18%	32,860 $1.18 Million
Q1 2020 May 06, 2020	SELL	$25.83 - $45.71 $993,163 - $1.76 Million	-38,450 Reduced 53.96%	32,800 $1.07 Million
Q4 2019 Feb 14, 2020	BUY	$37.87 - $45.37 $512,381 - $613,856	13,530 Added 23.44%	71,250 $3.22 Million
Q2 2019 Aug 13, 2019	SELL	$34.91 - $42.98 $308,080 - $379,298	-8,825 Reduced 13.26%	57,720 $2.48 Million
Q1 2019 May 14, 2019	SELL	$32.91 - $40.75 $513,725 - $636,107	-15,610 Reduced 19.0%	66,545 $2.55 Million
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $719,795 - $885,622	-22,685 Reduced 21.64%	82,155 $2.9 Million
Q3 2018 Nov 13, 2018	SELL	$32.83 - $38.63 $1.71 Million - $2.02 Million	-52,205 Reduced 33.24%	104,840 $4.04 Million
Q1 2018 May 14, 2018	BUY	$25.2 - $28.54 $1,260 - $1,427	50 Added 0.03%	157,045 $4.29 Million
Q4 2017 Feb 12, 2018	SELL	$24.79 - $29.8 $1.63 Million - $1.96 Million	-65,705 Reduced 29.5%	156,995 $3.89 Million
Q3 2017 Nov 08, 2017	SELL	$26.26 - $29.17 $233,714 - $259,613	-8,900 Reduced 3.84%	222,700 $6.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	231,600	231,600 $6.42 Million

Others Institutions Holding BSX

# of Institutions

1,558

Shares Held

1.18B

Call Options Held

6.78M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $141B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.

Account

Fuller & Thaler Asset Management, Inc. Boston Scientific Corp Transaction History